Barchart.com
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Biogen Inc (BIIB)

Biogen Inc (BIIB)
140.33 x 1 143.00 x 1
Post-market by (Cboe BZX)
140.33 -2.10 (-1.47%) 03/27/25 [NASDAQ]
140.33 x 1 143.00 x 1
Post-market 145.50 +5.17 (+3.68%) 16:38 ET
News & Headlines for Thu, Mar 27th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 Motley Fool - Thu Mar 27, 8:15AM CDT

Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to the company.

LLY : 821.67 (-0.62%)
BIIB : 140.33 (-1.47%)
SGH
3 Value Stocks Walking a Fine Line StockStory - Mon Mar 24, 8:02AM CDT

3 Value Stocks Walking a Fine Line

MTW : 9.43 (-0.32%)
SGH : 20.85 (+0.43%)
BIIB : 140.33 (-1.47%)
Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square GlobeNewswire - Mon Mar 24, 6:30AM CDT

BIIB : 140.33 (-1.47%)
MRNA
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks StockStory - Mon Mar 24, 4:01AM CDT

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

SRPT : 71.81 (-1.47%)
BMRN : 72.83 (+1.89%)
ABBV : 202.72 (+0.71%)
MRNA : 32.12 (+2.03%)
BIIB : 140.33 (-1.47%)
BIIB
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks StockStory - Thu Mar 20, 4:12AM CDT

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

BMRN : 72.83 (+1.89%)
VRTX : 502.55 (+0.45%)
MRNA : 32.12 (+2.03%)
UTHR : 308.02 (-0.90%)
BIIB : 140.33 (-1.47%)
Biogen Inc magnified-by Casimiro PT via Shutterstock
How Is Biogen's Stock Performance Compared to Other Biotech Stocks? Barchart - Wed Mar 19, 5:04AM CDT

Despite Biogen's underperformance compared to other biotech stocks over the past year, analysts remain moderately optimistic about its future prospects.

GILD : 111.16 (+1.73%)
XBI : 85.53 (+0.53%)
BIIB : 140.33 (-1.47%)
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients GlobeNewswire - Tue Mar 11, 6:30AM CDT

BIIB : 140.33 (-1.47%)
BIIB
3 Reasons BIIB is Risky and 1 Stock to Buy Instead StockStory - Mon Mar 3, 3:02AM CST

3 Reasons BIIB is Risky and 1 Stock to Buy Instead

WING : 229.29 (+4.05%)
BIIB : 140.33 (-1.47%)
Businessman trading stock market on teblet screen by Nespix via iStock
Is This the Most Undervalued Biotech Stock You Can Buy Right Now? Barchart - Wed Feb 26, 3:44PM CST

Biotech stock BIIB looks undervalued, but the company is also expected to deliver sluggish growth against declining revenues.

BIIB : 140.33 (-1.47%)
Biogen Inc magnified-by Casimiro PT via Shutterstock
Biogen Stock Outlook: Is Wall Street Bullish or Bearish? Barchart - Mon Feb 24, 6:58AM CST

Biogen has lagged well behind the broader market over the past year, yet analysts maintain a fairly optimistic outlook on its future performance.

$SPX : 5,693.31 (-0.33%)
IBRN : 23.37 (+0.29%)
PIPR : 253.79 (-3.71%)
BIIB : 140.33 (-1.47%)

Barchart Exclusives

Should You Buy the Dip in Rigetti Computing Stock in March 2025? Barchart - 1 hour ago
Rigetti Computing and other quantum computing stocks have been hit hard. So, is now the time to buy the dip? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot